Allergic bronchopulmonary aspergillosis in identical twins: Effectiveness of dupilumab.
作者信息
Lamothe Pedro A, Runnstrom Martin, Smirnova Natalia, Flores Flavio C, Shepherd Aaron, Park Jiwon, Lee F Eun-Hyung
机构信息
Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Ga.
Morehouse School of Medicine, Atlanta, Ga.
出版信息
J Allergy Clin Immunol Pract. 2023 May;11(5):1556-1558.e2. doi: 10.1016/j.jaip.2022.12.049. Epub 2023 Jan 25.
Abstract
摘要
相似文献
1
Allergic bronchopulmonary aspergillosis in identical twins: Effectiveness of dupilumab.
J Allergy Clin Immunol Pract. 2023 May;11(5):1556-1558.e2. doi: 10.1016/j.jaip.2022.12.049. Epub 2023 Jan 25.
2
A case of allergic bronchopulmonary aspergillosis in a child: Response to dupilumab.
J Allergy Clin Immunol Pract. 2024 Aug;12(8):2178-2179. doi: 10.1016/j.jaip.2024.04.018. Epub 2024 Apr 18.
3
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Cochrane Database Syst Rev. 2018 Mar 18;3(3):CD010288. doi: 10.1002/14651858.CD010288.pub4.
4
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Cochrane Database Syst Rev. 2015 Nov 4(11):CD010288. doi: 10.1002/14651858.CD010288.pub3.
5
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Cochrane Database Syst Rev. 2013 Sep 17(9):CD010288. doi: 10.1002/14651858.CD010288.pub2.
6
Allergic bronchopulmonary aspergillosis and omalizumab.
Allergy. 2011 Sep;66(9):1254-6. doi: 10.1111/j.1398-9995.2011.02599.x. Epub 2011 Apr 26.
7
Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Benralizumab in a Patient Who Did Not Respond to Omalizumab.
J Investig Allergol Clin Immunol. 2020;30(5):378-379. doi: 10.18176/jiaci.0564. Epub 2020 May 6.
8
Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.
J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1137-1139. doi: 10.1016/j.jaip.2017.01.013. Epub 2017 Mar 6.
9
Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab.
J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):111-3. doi: 10.1016/j.jaip.2013.08.014. Epub 2013 Oct 19.
10
Efficacy of dupilumab and biomarkers for systemic corticosteroid naïve allergic bronchopulmonary mycosis.
Allergol Int. 2021 Jan;70(1):145-147. doi: 10.1016/j.alit.2020.08.006. Epub 2020 Sep 8.
引用本文的文献
1
Treatment of allergic bronchopulmonary aspergillosis with biologics.
Chin Med J Pulm Crit Care Med. 2025 Jan 10;3(1):6-11. doi: 10.1016/j.pccm.2024.11.005. eCollection 2025 Mar.
2
Anti-IL-4Ra therapy is superior to other biologic classes in treating allergic bronchopulmonary aspergillosis.
J Allergy Clin Immunol Glob. 2024 Nov 12;4(1):100369. doi: 10.1016/j.jacig.2024.100369. eCollection 2025 Feb.
3
Allergic Bronchopulmonary Aspergillosis/Mycosis: An Allergic Disease or an Eosinophilic Disease?
Intern Med. 2025 Feb 15;64(4):493-501. doi: 10.2169/internalmedicine.4386-24. Epub 2024 Sep 4.
4
Efficacy of Biologics in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis.
Lung. 2024 Aug;202(4):367-383. doi: 10.1007/s00408-024-00717-y. Epub 2024 Jun 19.
5
The origins and longevity of IgE responses as indicated by serological and cellular studies in mice and humans.
Allergy. 2023 Dec;78(12):3103-3117. doi: 10.1111/all.15799. Epub 2023 Jul 7.
本文引用的文献
1
Biologic Therapies for Severe Asthma.
N Engl J Med. 2022 Jan 13;386(2):157-171. doi: 10.1056/NEJMra2032506.
2
Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab.
Clin Transl Allergy. 2021 Dec;11(10):e12081. doi: 10.1002/clt2.12081.
3
Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of Chronic Eosinophilic Pneumonia and Allergic Bronchopulmonary Aspergillosis - Case series, Almoosa specialist hospital.
Respir Med Case Rep. 2021 Oct 1;34:101520. doi: 10.1016/j.rmcr.2021.101520. eCollection 2021.
4
Successful Treatment of Mepolizumab- and Prednisolone-resistant Allergic Bronchopulmonary Aspergillosis with Dupilumab.
Intern Med. 2021 Sep 1;60(17):2839-2842. doi: 10.2169/internalmedicine.6679-20. Epub 2021 Mar 1.
5
Adult-onset eosinophilic airway diseases.
Allergy. 2020 Dec;75(12):3087-3099. doi: 10.1111/all.14620. Epub 2020 Oct 23.
6
New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation.
J Allergy Clin Immunol. 2021 Apr;147(4):1261-1268.e5. doi: 10.1016/j.jaci.2020.08.029. Epub 2020 Sep 10.
7
Dupilumab treatment for allergic bronchopulmonary aspergillosis: A case series.
J Allergy Clin Immunol Pract. 2020 Feb;8(2):742-743. doi: 10.1016/j.jaip.2019.11.031. Epub 2019 Dec 4.
8
Inhibition of IL-13-induced periostin in airway epithelium attenuates cellular protein expression of MUC5AC.
Respirology. 2017 Jan;22(1):93-100. doi: 10.1111/resp.12873. Epub 2016 Aug 24.
9
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria.
Clin Exp Allergy. 2013 Aug;43(8):850-73. doi: 10.1111/cea.12141.
Zotero 插件